1 September 2018 in EP Europace
Sudden cardiac death (SCD) is a major cause of mortality presenting a significant unmet clinical need. Patients at risk of SCD are implanted with implantable cardioverter-defibrillators (ICDs) according to international guidelines based on clinical trial evidence. Implantable cardioverter-defibrillators are not inexpensive and not without problem in terms of inappropriate shocks and infection risk. Also, only a minority of patients implanted with the ICD ever use the device during its battery lifetime highlighting the fact that methods used for SCD risk stratification are inadequate. Better ways of predicting who is at risk of SCD are needed. In addition, there is no effective prevention due to the lack of understanding of the electrical mechanisms underlying SCD. Our group has been investigating the electrophysiological basis of ventricular fibrillation and have successfully applied our preclinical findings to translational studies in patients with ischaemic cardiomyopathy. We have developed two ECG markers which have been shown to be strong predictors of ventricular arrhythmias and SCD. Ongoing clinical studies are being carried out including a multicentre UK study to consolidate the evidence base. They are being incorporated into the technology, LifeMap, with the aim to develop a successful clinical tool for the assessment of SCD risk. We hereby present the scientific data leading to the technology and the development to date. The information provided here was presented at the European Heart Rhythm Association (EHRA) Europace/Cardiostim conference at which LifeMap won the EHRA Inventors Award 2016.
30 July 2018 in BMJ Case Reports
11 June 2021 in BMJ Case Reports
We report the first leadless pacemaker (L-PM) providing atrioventricular synchronous pacing implanted into a heart transplant patient receiving chronic immunosuppressive therapy. The patient presented with syncope corresponding to sinus rhythm with high-grade atrioventricular block. Previously, L-PMs provided only single-chamber ventricular sensing and pacing. A Micra AV lL-PM provides atrioventricular synchronous pacing by tracking mechanical atrial contraction. L-PMs, which now support broader indications, should be considered in patients at greater risk of infection.
1 June 2020 in EP Europace
Funding Acknowledgements: This work was supported by the NIHR Leicester Biomedical Research Centre. XL was funded by MRC(MR/S037306/1) and BHF (PG/18/33/33780) Background: It remains controversial as to whether rotors detected using phase mapping during persistent atrial fibrillation (persAF) represent main drivers of the underlying mechanism as others found rotors to be located near line of conduction block. Regional electrogram desynchronization (RED) has been suggested as successful targets for persAF ablation, but automatic tools and quantitative measures are lacking. Purpose: We aim to use mean phase coherence (MPC) to automatically identify RED regions during persAF. This method was compared with phase singularity density (PSD) maps. Methods: Patients undergoing left atrial (LA) persAF ablation were enrolled (n = 10). 2048-channel virtual electrograms (VEGMs) were collected from each patient using non-contact mapping (St Jude Velocity System, Ensite Array) for 10 seconds. To remove far field ventricular activities, QRS onset and T wave end locations were detected from ECG lead I (Figure 1A) and only the VEGM segments from T end to QRS onset were included in the analysis. VEGMs were reconstructed using sinusoidal wavelets fitting and the phase of VEGMs determined using Hilbert transform. Phase singularities (PS) were detected using the topological charge method and repetitive PSD maps were generated. RED was defined as the average of MPC of each node against direct neighbouring nodes on the 3D mesh (Figure 1A-B). Linear regression analysis was used to compare the average MPC vs. PSD and vs. the standard deviation of MPC (MPC_SD). Results: A total of 221,184 VEGM segments were analysed with mean duration of 364.2 milliseconds. MPC has shown the ability to quantify the level of synchronisation between VEGMs (Figure 1B). Inverse correlation was found between PSD and average MPC values for all 10 patients (p < 0.0001, Figure 1C). Average MPC and MPC_SD were found to be inversely correlated (p < 0.0001, Figure 1C). Spatially, similar graphic patterns can be found from LA MPC maps and PSD maps for all patients (Figure 1D). Conclusion: We have proposed a method to quantify the level of synchronisation between VEGMs. Phase density mapping showed a considerable agreement with RED regions reflecting regional conducting delays, which supports the previous finding where rotors found at conduction block. Inverse correlation between local average MPC and MPC_SD suggests that conduction delays of the identified regions are not heterogenous, posing directional preferences. Rather than solely looking for rotational activities, this method could identify comprehensive RED regions, which may also explain the conflicting results from different studies targeting rotational activities, where incomplete subsets of RED regions could have been targeted. Atrial RED regions can easily be identified with simultaneously collected electrograms from multi-polar catheters and should be targeted in future persAF studies. Abstract Figure 1
1 April 2019 in Postgraduate Medical Journal
Purpose Implantable cardioverter defibrillator (ICD) implantation rates remain variable despite established guideline recommendations. This study aims to assess whether being managed by a cardiologist has an impact on whether patients are considered for an ICD for primary prevention of sudden cardiac death. Design/Methods Single-centre, retrospective, observational study of patients identified to have severe left ventricular systolic dysfunction (LVSD) on echocardiography (n = 129) between 1 and 30 June 2016 with cross-sectional assessment at 1 year. An assessment of ICD consideration at 1 year following the echocardiogram was documented, in addition to the specialty of the managing physician (group 1—electrophysiologist/heart failure specialist; group 2—all other cardiologists; group 3—non-cardiologist). Results 129/1173 (11%) transthoracic echocardiographies (s) were identified to have severe LVSD. 52 (40%), 37 (29%) and 40 (31%) were managed by group 1, group 2 and group 3, respectively. Mean age was 74.7 (±12.6) years with a predominance of male gender (70.5%). An ICD was not considered in 47.3%. Those managed by a cardiologist were more likely to be considered for an ICD than a non-cardiologist (63.9% vs 30.0%; OR 4.0, 95% CI 1.8 to 8.8, p = 0.001) with a greater survival at 1 year (89.9% vs 52.5%, OR 8.1 95% CI 3.2 to 20.4, p < 0.001). Group 1 were more likely to consider ICD than group 2 cardiologists (75.0% vs 45.9%; OR 3.5; 95% CI 1.4 to 8.7, p = 0.005). Conclusion There is significant variation between cardiologists and non-cardiologists, as well as within different cardiology subspecialists, when considering the option of ICD therapy for primary prevention.